Koji Sagane

Splicing factor SF3b as a target of the antitumor natural product pladienolide

Yoshihiko Kotake, Koji Sagane, Takashi Owa et al. · Nature Chemical Biology · 2007 · 649 citations · Full text

Oncogenic Agent, Medicine, Factor Sf3b +5

Selective degradation of splicing factor CAPERα by anticancer sulfonamides

Taisuke Uehara, Yukinori Minoshima, Koji Sagane et al. · Nature Chemical Biology · 2017 · 366 citations

Medicinal Chemistry, Medicine, Natural Sciences +6

Biological validation that SF3b is a target of the antitumor macrolide pladienolide

Akira Yokoi, Yoshihiko Kotake, Kentaro Takahashi et al. · FEBS Journal · 2011 · 178 citations · Full text

Widr Cells, Tumor Biology, Oncology +14

Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice

Koji Sagane, Kazuhiro Hayakawa, Junko Kai et al. · BMC Neuroscience · 2005 · 167 citations · Full text

E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol Biosynthesis

Naoaki Watanabe, Mamiko Miyazaki, Takaaki Horii et al. · Antimicrobial Agents and Chemotherapy · 2011 · 164 citations · Full text

Microbial Pathogens, Fungal Cell Biology, Glycobiology +16